Causal association between gut microbiome and polycystic ovary syndrome: A bidirectional Mendelian randomization study
), Linjie Xu(2), Xi Cheng(3), Chenglu Li(4), Siyi Chen(5), Yuquan Zhang(6),
(1) Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China. Rugao Maternity Hospital, Rugao 226500, Jiangsu, China
(2) Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China
(3) Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China
(4) Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China
(5) Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China
(6) Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China
Corresponding Author
Abstract
References
Rao P and Bhide P. Controversies in the diagnosis of
polycystic ovary syndrome. Ther Adv Reprod Health.
; 14:2633494120913032.
Norman RJ, Dewailly D, Legro RS and Hickey TE. Polycystic
ovary syndrome. Lancet. 2007; 370(9588):685-97.
Butts SF, Seifer DB, Koelper N, Senapati S, Sammel MD,
Hoofnagle AN, Kelly A, Krawetz SA, Santoro N,
Zhang H, Diamond MP, Legro RS, Eunice Kennedy
Shriver National Institute of Child H and Human
Development Reproductive Medicine N. Vitamin D
Deficiency Is Associated With Poor Ovarian
Stimulation Outcome in PCOS but Not Unexplained
Infertility. J Clin Endocrinol Metab. 2019;
(2):369-378.
Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC,
Laven JS and Legro RS. Scientific Statement on the
Diagnostic Criteria, Epidemiology, Pathophysiology,
and Molecular Genetics of Polycystic Ovary
Syndrome. Endocr Rev. 2015; 36(5):487-525.
Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T,
Daniali M, Nikfar S, Tsatsakis A and Abdollahi M.
Polycystic Ovary Syndrome: A Comprehensive
Review of Pathogenesis, Management, and Drug
Repurposing. Int J Mol Sci. 2022; 23(2)
Damone AL, Joham AE, Loxton D, Earnest A, Teede HJ and
Moran LJ. Depression, anxiety and perceived stress in
women with and without PCOS: a community-based
study. Psychol Med. 2019; 49(9):1510-1520.
Jin P and Xie Y. Treatment strategies for women with
polycystic ovary syndrome. Gynecol Endocrinol.
; 34(4):272-277.
Vink JM, Sadrzadeh S, Lambalk CB and Boomsma DI.
Heritability of polycystic ovary syndrome in a Dutch
twin-family study. J Clin Endocrinol Metab. 2006;
(6):2100-4.
Abbott DH, Dumesic DA, Eisner JR, Colman RJ and Kemnitz
JW. Insights into the development of polycystic ovary
syndrome (PCOS) from studies of prenatally
androgenized female rhesus monkeys. Trends
Endocrinol Metab. 1998; 9(2):62-7.
Zhang J, Liu Y, Liu X, Xu L, Zhou L, Tang L, Zhuang J,
Guo W and Hu R. High Intake of Energy and Fat in
Southwest Chinese Women with PCOS: A
Population-Based Case-Control Study. PLoS One.
; 10(5):e0127094.
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh
C, Nielsen T, Pons N, Levenez F, Yamada T, Mende
DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H,
Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto
JM, Hansen T, Le Paslier D, Linneberg A, Nielsen
HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner
K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang
X, Li S, Qin N, Yang H, Wang J, Brunak S, Dore J,
Guarner F, Kristiansen K, Pedersen O, Parkhill J,
Weissenbach J, Meta HITC, Bork P, Ehrlich SD and
Wang J. A human gut microbial gene catalogue
established by metagenomic sequencing. Nature.
; 464(7285):59-65.
Tremellen K and Pearce K. Dysbiosis of Gut Microbiota
(DOGMA)--a novel theory for the development of
Polycystic Ovarian Syndrome. Med Hypotheses.
; 79(1):104-12.
Sun MF and Shen YQ. Dysbiosis of gut microbiota and
microbial metabolites in Parkinson's Disease. Ageing
Res Rev. 2018; 45:53-61.
Jobira B, Frank DN, Pyle L, Silveira LJ, Kelsey MM,
Garcia-Reyes Y, Robertson CE, Ir D, Nadeau KJ and
Cree-Green M. Obese Adolescents With PCOS Have
Altered Biodiversity and Relative Abundance in
Gastrointestinal Microbiota. J Clin Endocrinol Metab.
; 105(6):e2134-44.
Li N, Li Y, Qian C, Liu Q, Cao W, Ma M, He R, Chen R,
Geng R and Liu Y. Dysbiosis of the Saliva
Microbiome in Patients With Polycystic Ovary
Syndrome. Front Cell Infect Microbiol. 2020;
:624504.
Kurilshikov A, Medina-Gomez C, Bacigalupe R,
Radjabzadeh D, Wang J, Demirkan A, Le Roy CI,
Raygoza Garay JA, Finnicum CT, Liu X, Zhernakova
DV, Bonder MJ, Hansen TH, Frost F, Ruhlemann MC,
Turpin W, Moon JY, Kim HN, Lull K, Barkan E, Shah
SA, Fornage M, Szopinska-Tokov J, Wallen ZD,
Borisevich D, Agreus L, Andreasson A, Bang C,
Bedrani L, Bell JT, Bisgaard H, Boehnke M,
Boomsma DI, Burk RD, Claringbould A, Croitoru K,
Davies GE, van Duijn CM, Duijts L, Falony G, Fu J,
van der Graaf A, Hansen T, Homuth G, Hughes DA,
Ijzerman RG, Jackson MA, Jaddoe VWV, Joossens
M, Jorgensen T, Keszthelyi D, Knight R, Laakso M,
Laudes M, Launer LJ, Lieb W, Lusis AJ, Masclee
AAM, Moll HA, Mujagic Z, Qibin Q, Rothschild D,
Shin H, Sorensen SJ, Steves CJ, Thorsen J, Timpson
NJ, Tito RY, Vieira-Silva S, Volker U, Volzke H,
Vosa U, Wade KH, Walter S, Watanabe K, Weiss S,
Weiss FU, Weissbrod O, Westra HJ, Willemsen G,
Payami H, Jonkers D, Arias Vasquez A, de Geus EJC,
Meyer KA, Stokholm J, Segal E, Org E, Wijmenga C,
Kim HL, Kaplan RC, Spector TD, Uitterlinden AG,
Rivadeneira F, Franke A, Lerch MM, Franke L, Sanna
S, D'Amato M, Pedersen O, Paterson AD, Kraaij R,
Raes J and Zhernakova A. Large-scale association
analyses identify host factors influencing human gut
microbiome composition. Nat Genet. 2021;
(2):156-165.
McAllister JM, Legro RS, Modi BP, Strauss JF and 3rd.
Functional genomics of PCOS: from GWAS to
molecular mechanisms. Trends Endocrinol Metab.
; 26(3):118-24.
Greenland S. An introduction to instrumental variables for
epidemiologists. Int J Epidemiol. 2000; 29(4): 722-
Burgess S and Thompson SG. Mendelian randomization :
methods for causal inference using genetic variants.
Second edition. ed. Chapman & Hall/CRC
interdisciplinary statistics series. CRC Press/Chapman
& Hall,Taylor and Francis Group; 2021.
Jia J, Dou P, Gao M, Kong X, Li C, Liu Z and Huang T.
Assessment of Causal Direction Between Gut
Microbiota-Dependent Metabolites and
Cardiometabolic Health: A Bidirectional Mendelian
Randomization Analysis. Diabetes. 2019; 68(9):1747-
Bowden J, Davey Smith G and Burgess S. Mendelian
randomization with invalid instruments: effect
estimation and bias detection through Egger
regression. Int J Epidemiol. 2015; 44(2):512-25.
FinnGen. FinnGen R8 release.
https://console.cloud.google.com/storage/browser/fin
ngen-public-datar8/summary_stats;tab=objects?prefix=&forceOnObje
ctsSortingFiltering=true
Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich
Vila A, Vosa U, Mujagic Z, Masclee AAM, Jonkers
D, Oosting M, Joosten LAB, Netea MG, Franke L,
Zhernakova A, Fu J, Wijmenga C and McCarthy MI.
Causal relationships among the gut microbiome,
short-chain fatty acids and metabolic diseases. Nat
Genet. 2019; 51(4):600-605.
Li P, Wang H, Guo L, Gou X, Chen G, Lin D, Fan D, Guo
X and Liu Z. Association between gut microbiota and
preeclampsia-eclampsia: a two-sample Mendelian
randomization study. BMC Med. 2022; 20(1):443.
Burgess S, Butterworth A and Thompson SG. Mendelian
randomization analysis with multiple genetic variants
using summarized data. Genet Epidemiol. 2013;
(7):658-65.
Bowden J, Davey Smith G, Haycock PC and Burgess S.
Consistent Estimation in Mendelian Randomization
with Some Invalid Instruments Using a Weighted
Median Estimator. Genet Epidemiol. 2016; 40(4):304-
Hartwig FP, Davey Smith G and Bowden J. Robust inference
in summary data Mendelian randomization via the
zero modal pleiotropy assumption. Int J Epidemiol.
; 46(6):1985-1998.
Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V,
Baird D, Laurin C, Burgess S, Bowden J, Langdon R,
Tan VY, Yarmolinsky J, Shihab HA, Timpson NJ,
Evans DM, Relton C, Martin RM, Davey Smith G,
Gaunt TR and Haycock PC. The MR-Base platform
supports systematic causal inference across the human
phenome. Elife. 2018; 7
Bowden J and Holmes MV. Meta-analysis and Mendelian
randomization: A review. Res Synth Methods. 2019;
(4):486-496.
Lawlor DA, Harbord RM, Sterne JA, Timpson N and Davey
Smith G. Mendelian randomization: using genes as
instruments for making causal inferences in
epidemiology. Stat Med. 2008; 27(8):1133-63.
Verbanck M, Chen CY, Neale B and Do R. Detection of
widespread horizontal pleiotropy in causal
relationships inferred from Mendelian randomization
between complex traits and diseases. Nat Genet. 2018;
(5):693-698.
Zhang Y, Mao Q, Li Y, Cheng J, Xia Q, Chen G, Chen P,
Jin S, Li D, Zhong C, Yang J, Fan X, Liang Y and Lin
H. Cancer and COVID-19 Susceptibility and Severity:
A Two-Sample Mendelian Randomization and
Bioinformatic Analysis. Front Cell Dev Biol. 2021;
:759257.
Douglas Staiger JHS. Instrumental variables regression with
weak. 1994;
Hemani G, Tilling K and Davey Smith G. Orienting the
causal relationship between imprecisely measured
traits using GWAS summary data. PLoS Genet. 2017;
(11):e1007081.
Guo Y, Qi Y, Yang X, Zhao L, Wen S, Liu Y and Tang L.
Association between Polycystic Ovary Syndrome and
Gut Microbiota. PLoS One. 2016; 11(4):e0153196.
Kelley ST, Skarra DV, Rivera AJ and Thackray VG. The
Gut Microbiome Is Altered in a Letrozole-Induced
Mouse Model of Polycystic Ovary Syndrome. PLoS
One. 2016; 11(1):e0146509.
Torres PJ, Siakowska M, Banaszewska B, Pawelczyk L,
Duleba AJ, Kelley ST and Thackray VG. Gut
Microbial Diversity in Women With Polycystic Ovary
Syndrome Correlates With Hyperandrogenism. J Clin
Endocrinol Metab. 2018; 103(4):1502-1511.
Insenser M, Murri M, Del Campo R, Martinez-Garcia MA,
Fernandez-Duran E and Escobar-Morreale HF. Gut
Microbiota and the Polycystic Ovary Syndrome:
Influence of Sex, Sex Hormones, and Obesity. J Clin
Endocrinol Metab. 2018; 103(7):2552-2562.
Guo J, Shao J, Yang Y, Niu X, Liao J, Zhao Q, Wang D, Li
S and Hu J. Gut Microbiota in Patients with Polycystic
Ovary Syndrome: a Systematic Review. Reprod Sci.
; 29(1):69-83.
Zhou L, Ni Z, Cheng W, Yu J, Sun S, Zhai D, Yu C and Cai
Z. Characteristic gut microbiota and predicted
metabolic functions in women with PCOS. Endocr
Connect. 2020; 9(1):63-73.
Deng Y, Zhou M, Wang J, Yao J, Yu J, Liu W, Wu L, Wang
J and Gao R. Involvement of the microbiota-gut-brain
axis in chronic restraint stress: disturbances of the
kynurenine metabolic pathway in both the gut and
brain. Gut Microbes. 2021; 13(1):1-16.
Liang Y, Ming Q, Liang J, Zhang Y, Zhang H and Shen T.
Gut microbiota dysbiosis in polycystic ovary
syndrome: association with obesity - a preliminary
report. Can J Physiol Pharmacol. 2020; 98(11):803-
Liu R, Zhang C, Shi Y, Zhang F, Li L, Wang X, Ling Y, Fu
H, Dong W, Shen J, Reeves A, Greenberg AS, Zhao
L, Peng Y and Ding X. Dysbiosis of Gut Microbiota
Associated with Clinical Parameters in Polycystic
Ovary Syndrome. Front Microbiol. 2017; 8:324.
Dong S, Jiao J, Jia S, Li G, Zhang W, Yang K, Wang Z, Liu
C, Li D and Wang X. 16S rDNA Full-Length
Assembly Sequencing Technology Analysis of
Intestinal Microbiome in Polycystic Ovary Syndrome.
Front Cell Infect Microbiol. 2021; 11:634981.
Fu J, Bonder MJ, Cenit MC, Tigchelaar EF, Maatman A,
Dekens JA, Brandsma E, Marczynska J, Imhann F,
Weersma RK, Franke L, Poon TW, Xavier RJ, Gevers
D, Hofker MH, Wijmenga C and Zhernakova A. The
Gut Microbiome Contributes to a Substantial
Proportion of the Variation in Blood Lipids. Circ Res.
; 117(9):817-24.
Mancabelli L, Milani C, Lugli GA, Turroni F, Cocconi D,
van Sinderen D and Ventura M. Identification of
universal gut microbial biomarkers of common human
intestinal diseases by meta-analysis. FEMS Microbiol
Ecol. 2017; 93(12)
Waters JL and Ley RE. The human gut bacteria
Christensenellaceae are widespread, heritable, and
associated with health. BMC Biol. 2019; 17(1):83.
Chang CJ, Lin TL, Tsai YL, Wu TR, Lai WF, Lu CC and
Lai HC. Next generation probiotics in disease
amelioration. J Food Drug Anal. 2019; 27(3):615-622.
Zeng B, Lai Z, Sun L, Zhang Z, Yang J, Li Z, Lin J and
Zhang Z. Structural and functional profiles of the gut
microbial community in polycystic ovary syndrome
with insulin resistance (IR-PCOS): a pilot study. Res
Microbiol. 2019; 170(1):43-52.
Zhang J, Sun Z, Jiang S, Bai X, Ma C, Peng Q, Chen K,
Chang H, Fang T and Zhang H. Probiotic
Bifidobacterium lactis V9 Regulates the Secretion of
Sex Hormones in Polycystic Ovary Syndrome Patients
through the Gut-Brain Axis. mSystems. 2019; 4(2)
Grasset E, Puel A, Charpentier J, Collet X, Christensen JE,
Terce F and Burcelin R. A Specific Gut Microbiota
Dysbiosis of Type 2 Diabetic Mice Induces GLP-1
Resistance through an Enteric NO-Dependent and
Gut-Brain Axis Mechanism. Cell Metab. 2017;
(1):278.
Chavez-Carbajal A, Nirmalkar K, Perez-Lizaur A,
Hernandez-Quiroz F, Ramirez-Del-Alto S, GarciaMena J and Hernandez-Guerrero C. Gut Microbiota
and Predicted Metabolic Pathways in a Sample of
Mexican Women Affected by Obesity and Obesity
Plus Metabolic Syndrome. Int J Mol Sci. 2019; 20(2)
Mammadova G, Ozkul C, Yilmaz Isikhan S, Acikgoz A and
Yildiz BO. Characterization of gut microbiota in
polycystic ovary syndrome: Findings from a lean
population. Eur J Clin Invest. 2021; 51(4):e13417.
Hall AB, Yassour M, Sauk J, Garner A, Jiang X, Arthur T,
Lagoudas GK, Vatanen T, Fornelos N, Wilson R,
Bertha M, Cohen M, Garber J, Khalili H, Gevers D,
Ananthakrishnan AN, Kugathasan S, Lander ES,
Blainey P, Vlamakis H, Xavier RJ and Huttenhower
C. A novel Ruminococcus gnavus clade enriched in
inflammatory bowel disease patients. Genome Med.
; 9(1):103.
Zhou L, Ni Z, Yu J, Cheng W, Cai Z and Yu C. Correlation
Between Fecal Metabolomics and Gut Microbiota in
Obesity and Polycystic Ovary Syndrome. Front
Endocrinol (Lausanne). 2020; 11:628.
Tian Y, Zhang W, Zhao S, Sun Y, Bian Y, Chen T, Du Y,
Zhang J, Wang Z, Huang T, Peng Y, Yang P, Zhao H
and Chen ZJ. FADS1-FADS2 gene cluster confers
risk to polycystic ovary syndrome. Sci Rep. 2016;
:21195.
Khajeh M, Rahbarghazi R, Nouri M and Darabi M. Potential
role of polyunsaturated fatty acids, with particular
regard to the signaling pathways of arachidonic acid
and its derivatives in the process of maturation of the
oocytes: Contemporary review. Biomed
Pharmacother. 2017; 94:458-467.
Burgess S, Davies NM and Thompson SG. Bias due to
participant overlap in two-sample Mendelian
randomization. Genet Epidemiol. 2016; 40(7):597-
Article Metrics
Abstract View
: 1520 times
Download : 317 times
Refbacks
- There are currently no refbacks.




